Stay updated with breaking news from Additional Condition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Unintended downstream consequences are likely to abound in the wake of the June 24, 2022 Dobbs decision that overruled Roe v. Wade, as Mintz attorneys have addressed in other contexts...
Unintended downstream consequences are likely to abound in the wake of the June 24, 2022 Dobbs decision that overruled Roe v. Wade, as Mintz attorneys have addressed in other contexts here and here...
On June 27, the U.S. Food and Drug Administration (FDA) published the long-awaited proposed rule “Nonprescription Drug Product with an Additional Condition for Nonprescription Use”...
Proposed rule is intended to increase options for the development of safe and effective nonprescription drugs.
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration is proposing a rule that will broaden the range of nonprescription or over-the counter drugs available to consumers.The rule titled